Relapsed multiple myeloma demands specialist expertise that goes beyond general oncology. Academic centers with dedicated myeloma programs offer access to clinical trials, advanced cytogenetic interpretation, and treatment-line sequencing strategies that can significantly impact outcomes. Key Takeaways Seek second opinions from dedicated myeloma programs at academic medical centers with specialists who actively participate in clinical trials and interpret cytogenetic markers